Phase Forward reports 17% increase in GAAP revenues for first-quarter 2010

NewsGuard 100/100 Score

Phase Forward Incorporated (NASDAQ: PFWD) today announced its financial results for the first quarter of 2010.

For the first quarter of 2010, GAAP revenues were $57.2 million, a 17% increase from $48.8 million in the first quarter of 2009. GAAP income from operations was $3.1 million for the first quarter of 2010, compared to $5.2 million in the first quarter of 2009. GAAP net income for the period was $1.9 million, or $0.05 per diluted share, compared to GAAP net income of $4.1 million, or $0.09 per diluted share in the first quarter of 2009.

Non-GAAP revenues were $57.5 million for the first quarter of 2010, which excludes a $296,000 purchase accounting adjustment to record deferred revenues and backlog assumed in acquisitions at fair value. Non-GAAP income from operations was $8.3 million, compared to $9.1 million in the prior year period and representing a non-GAAP operating margin of 14%. Non-GAAP net income for the period was $5.2 million, or $0.12 per diluted share, compared to $6.7 million, or $0.15 per diluted share, in the first quarter of 2009.

The attached table presents a reconciliation of GAAP to non-GAAP revenues, income from operations and net income and net income per share applicable to common stockholders for the three months ended March 31, 2009 and 2010. Non-GAAP results exclude the impact of stock-based compensation expense, amortization of intangible assets, the effects of purchase accounting adjustments to record deferred revenues and backlog assumed in acquisitions at fair value.

Total cash, cash equivalents and investments were $129.7 million at the end of the first quarter, a decrease of $5.8 million from $135.5 million at the end of the prior quarter. The decrease in cash was driven by $26.0 million in cash used to repurchase shares of the company's stock and $3.0 million in capital spending which was partially offset by $23.4 million in cash flow from operations. Total deferred revenues were $110.4 million at the end of the quarter, up from $98.4 million at the end of the prior quarter and $95.8 million at the end of the first quarter of 2009.

SOURCE Phase Forward

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.